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Journal of Hepatology 48 (2008) 676–677To the Editor:
I read with interest an excellent study aiming at eluci-
dating the mechanisms of microcirculatory dysfunction
in liver during sepsis by Dr. Singer and colleagues [1].
In both endotoxin-sensitive and insensitive mice, cecal
ligation and puncture (CLP) resulted in the accumula-
tion of leukocytes and platelets in terminal hepatic ven-
ules, blood cell recruitment in sinusoids, and increased
nonperfused sinusoids. CLP elicited also increases in
the expression of myeloid diﬀerentiation factor 88 and
Toll-like receptor 2, both of which have an important
role in the signaling of endotoxin and other toxins.
These ﬁndings caused by CLP were similar to those in
mice subjected to a moderate dose of endotoxin. At
the end of this experiment, endotoxin was not detected
in CLP mice, whereas mean endotoxin levels were
653.7 Endotoxin Unit (EU)/ml in the portal blood and
561.4 EU/ml in inferior vena cava following intraperito-
neal injection of endotoxin at a dose of 500 lg/kg. Based
on the above ﬁndings, the authors conclude that endo-
toxin does not play a critical role in the hepatic micro-
vascular disturbances in mice after CLP, which is a
model of polymicrobial sepsis in human.
Microcirculatory dysfunction lies at the center of sep-
sis pathogenesis. This study may shed light on the
underlying mechanisms of sepsis-induced microvascular
dysfunction leading to hepatic failure. I would like to
raise some issues concerning the endotoxin concentra-
tions. Although 1 EU was initially deﬁned as the endo-
toxin activity of 200 pg of a Reference Standard
Endotoxin, the conversion ratio is dependent on the
source of the endotoxin. There is a considerable varia-
tion of the equation, ranging from 1 EU to 20 pg to 1
EU to 500 pg. I would like to ask the authors whether
endotoxin concentrations should be expressed as pg/ml
rather than EU/ml because the authors determined thedoses of endotoxin injected to the mice to be 50 or
500 lg/kg. The absence of endotoxin in the blood does
not necessarily indicate that endotoxin is not involved
in the hepatic microvascular dysfunction in mice sub-
jected to CLP. Prompt clearance of endotoxin has been
observed. For example, in a human model of acute
endotoxemia evoked by a bolus injection of 2 ng/kg of
endotoxin, endotoxin is rapidly cleared from the circula-
tion within 30 min [2].
Rapid binding of endotoxin to the target cell has also
been identiﬁed. In vitro, endotoxin is able to bind the cell
surface within 1 min of exposure, and only 5–15 min
exposure is suﬃcient to trigger maximal TNF-a release
[3].
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